Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3. (2020)

First Author: Prudencio M
Attributed to:  JPND European Spinocerebellar Ataxia Type 3/Machado-Joseph Disease Initiative funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.abb7086

PubMed Identifier: 33087504

Publication URI: http://europepmc.org/abstract/MED/33087504

Type: Journal Article/Review

Volume: 12

Parent Publication: Science translational medicine

Issue: 566

ISSN: 1946-6234